LEI 21380029O1RSZIAVOR95

UCB BIOPHARMA

Group parent: U C B

Awards tracked

39

Value

€13.11M

Countries

BE

Download sample CSV

Contract awards & public grants

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → UCB BIOPHARMA

European Commission · BE · Grant · 2026-06-02

—

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies → UCB BIOPHARMA

European Commission · BE · Grant · 2025-11-03

—

101218845 - UNIFIED - UNIFYING FRAMEWORK FOR PATIENT-CENTRED CLINICAL-STUDY ENDPOINTS DERIVED FROM DIGITAL HEALTH TECHNOLOGIES → UCB BIOPHARMA

IMI - Innov.Health Initiative · BE · Grant · 2025-11-01

€12.6M

Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases → UCB BIOPHARMA

European Commission · BE · Grant · 2024-12-12

—

IMAGING FOR PATIENT BENEFIT IN ARTHRITIS → UCB BIOPHARMA

European Commission · BE · Grant · 2024-12-10

—

Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing → UCB BIOPHARMA

European Commission · BE · Grant · 2024-12-05

—

REpresentative Clinical Research - ADvancing Inclusivity in Europe → UCB BIOPHARMA

European Commission · BE · Grant · 2024-12-05

—

EUROPEAN RARE DISEASES RESEARCH ALLIANCE → UCB BIOPHARMA

European Commission · BE · Grant · 2024-08-20

—

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research → UCB BIOPHARMA

European Commission · BE · Grant · 2024-07-26

—

European platform for neurodegenerative disorders → UCB BIOPHARMA

European Commission · BE · Grant · 2021-10-25

—

Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies → UCB BIOPHARMA

European Commission · BE · Grant · 2021-10-13

—

Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States → UCB BIOPHARMA

European Commission · BE · Grant · 2021-06-29

—

Central Repository for Digital Pathology → UCB BIOPHARMA

European Commission · BE · Grant · 2020-11-26

—

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment → UCB BIOPHARMA

European Commission · BE · Grant · 2020-11-12

—

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory → UCB BIOPHARMA

European Commission · BE · Grant · 2019-12-18

—

PharmaLedger → UCB BIOPHARMA

European Commission · BE · Grant · 2019-12-16

—

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. → UCB BIOPHARMA

European Commission · BE · Grant · 2019-08-19

€256,320

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials → UCB BIOPHARMA

European Commission · BE · Grant · 2019-08-07

—

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed w → UCB BIOPHARMA

European Commission · BE · Grant · 2019-05-06

—

Neurotoxicity De-Risking in Preclinical Drug Discovery → UCB BIOPHARMA

European Commission · BE · Grant · 2019-03-15

—

EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells → UCB BIOPHARMA

European Commission · BE · Grant · 2019-02-28

—

Biomarkers in Atopic Dermatitis and Psoriasis → UCB BIOPHARMA

European Commission · BE · Grant · 2019-02-27

—

PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease → UCB BIOPHARMA

European Commission · BE · Grant · 2019-02-19

—

European Screening Centre; Unique Library for Attractive Biology → UCB BIOPHARMA

European Commission · BE · Grant · 2018-12-18

—

European Health Data and Evidence Network → UCB BIOPHARMA

European Commission · BE · Grant · 2018-11-22

—

Continuous Downstream Processing of Bioproducts → UCB BIOPHARMA

European Commission · BE · Grant · 2018-08-30

—

The GetReal Initiative → UCB BIOPHARMA

European Commission · BE · Grant · 2018-06-26

—

conect4children (COllaborative Network for European Clinical Trials For Children) → UCB BIOPHARMA

European Commission · BE · Grant · 2018-06-22

—

Autism Innovative Medicine Studies – 2 – Trials → UCB BIOPHARMA

European Commission · BE · Grant · 2018-06-22

—

Ensuring the future of EUPATI beyond 2020 → UCB BIOPHARMA

European Commission · BE · Grant · 2018-06-21

—

Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production → UCB BIOPHARMA

European Commission · BE · Grant · 2018-06-21

—

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medici → UCB BIOPHARMA

European Commission · BE · Grant · 2018-06-04

—

Rheuma Tolerance for Cure → UCB BIOPHARMA

European Commission · BE · Grant · 2017-08-25

—

European Quality In Preclinical Data → UCB BIOPHARMA

European Commission · BE · Grant · 2017-08-18

—

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 → UCB BIOPHARMA

European Commission · BE · Grant · 2017-01-30

—

Remote Assessment of Disease and Relapse in Central Nervous System Disorders → UCB BIOPHARMA

European Commission · BE · Grant · 2016-03-31

—

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → UCB BIOPHARMA

European Commission · BE · Grant · 2015-09-02

—

ISOTOPIC LABELING FOR DRUG INNOVATION → UCB BIOPHARMA

European Commission · BE · Grant · 2015-08-10

€250,560

Targeted small-molecule Stabilisation of Protein-Protein Interactions → UCB BIOPHARMA

European Commission · BE · Grant · 2015-07-20

—

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.